Estrogen-induced regulation of the ATP-binding cassette transporter A1 (ABCA1) in mice: A possible mechanism of atheroprotection by estrogen

Molecular and Cellular Biochemistry

Volumn 240, Issue 1-2, 2002, Pages 67-73

  Srivastava, Rai Ajit K ^a  

^a CloneGen Biotechnology   (United States)

Author keywords

ABCA1; ApoA1 transgenic mice; Atherosclerosis; Estrogen; High fat

Indexed keywords

ABC TRANSPORTER; APOLIPOPROTEIN A1; CHOLIC ACID; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FAT; FENOFIBRATE; HIGH DENSITY LIPOPROTEIN; MESSENGER RNA; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROGENESIS; ATHEROSCLEROSIS; CIRCULATION; CONTROLLED STUDY; CORRELATION FUNCTION; DATA ANALYSIS; DIET THERAPY; DRUG MECHANISM; ESTROGEN DEFICIENCY; FEEDING; HEART PROTECTION; INTESTINE; LIPID DIET; LIVER LEVEL; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE; ANIMAL; ARTERIOSCLEROSIS; ARTICLE; BLOOD; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; PROTEIN BINDING; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA; EUKARYOTA; MUS MUSCULUS;

ANIMALS; APOLIPOPROTEIN A-I; ARTERIOSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; CHOLIC ACID; ESTRADIOL; ESTROGENS; FATS; GENE EXPRESSION REGULATION; INJECTIONS, SUBCUTANEOUS; LIPOPROTEINS, HDL; MICE; MICE, TRANSGENIC; PROCETOFEN; PROTEIN BINDING;

EID: 0036854696     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020604610873     Document Type: Review

References (36)

1. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, Dam MV, Yu L, Brewer C, Collins JA, Molhuizen HO, Loubser O, Ouelette BF, Fichter K, Ashbourne-Excoffon KJ, Sensen CW, Csherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJ, Hayden MR: Mutations in ABCA1 in Tangier disease and familial high density lipoprotein deficiency. Nat Genet 22: 336-345, 1999
2. Bodzioch M, Orso M, Klucken J, Langmann T, Bottcher A, Diederich W, Drobnik W, Barlage S, Buchler C, Porsch-Ozcurumez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G: The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22: 347-351, 1999
3. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denefle P, Assman G: Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22: 352-355, 1999
4. Rothblat GH, de la Llera-Moya M, Atger V, Kellner-Weibel G, Williams DL, Phillipis MC: Cell cholesterol efflux: integration of old and new observations provides new insights. J Lipid Res 40: 781-796, 1999
5. Oram JF, Yakoyama S: Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J Lipid Res 9: 155-167, 1996
6. Johnson WJ, Mahlberg FH, Rothblat GH, Phillipis MC: Cholesterol transport between cells and high density lipoprotein. Biochim Biophys Acta 1085: 273-298, 1991
7. McNeish J, Aiello RJ, Guyot D, Turi T, Gabel C, Aldinger C, Hoppe KL, Roach ML, Royer LJ, Wet JD, Broccardo C, Chimini G, Francone OL: High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc Natl Acad Sci USA 97: 4245-4350, 2000
8. Orso E, Broccardo C, Kaminiski WE, Bottcher A, Liebisch G, Drobnik W, Gotz A, Chambenoit O, Diedrich W, Langmann T, Spruss T, Luciani ME, Rothe G, Lackner KJ, Chimini G, Schmitz G: Transport of lipids from golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice. Nat Genet 24: 192-196, 2000
9. Singaraja RR, Bocher V, James ER, Clee SM, Zhang L, Leavitt BR, Tan B, Brooks-Wilson A, Kwok A, Bissada N, Yang Y, Liu G, Tafuri SR, Fievet C, Wellington CL, Staels B, Hayden MR: Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and apoA1-dependent efflux stimulated by an internal promoter containing liver X receptor response element in intron 1. J Biol Chem 276: 33969-33979, 2001
10. Vaisman BL, Lambert G, Amar M, Joyce C, Ito T, Shamburek RD, Cain WJ, Fruchart-Najib J, Neufeld ED, Remaley AT, Brewer HB Jr, Santamarina-Fojo S: ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice. J Clin Invest 108: 303-309, 2001
11. Clee SM, Kastelein JJ, van Dam M, Marcil M, Roomp K, Zwarts KY, Collins JA, Roelants R, Tamasawa N, Stulc T, Suda T, Caska R, Boucher B, Rondeau C, DeSouich C, Brook-Wilson A, Molhuiszen HO, Frohlich J, Genest J, Hayden MR: Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J Clin Invest 106: 1263-1270, 2000
12. Eck MV, Bos S, Kaminiski W, Orso E, Rothe G, Twisk J, Bottcher A, Amersfoort ESV, Christiansen-Weber TA, Fung-Leung W, Van Berkel TJC: Leukocyte ATP-binding cassette transporter A1 (ABCA1) deficiency promotes atherosclerotic lesion development. Scientific Session of The American Heart Association, Abstract number 465, November 2001
13. Baroukh N, Ostos MA, Vergnes L, Recalde D, Staels B, Fruchart J, Ochoa A, Castro G, Zakin MM: Expression of human apolipoprotein AI/CIII/AIV gene cluster in mice reduces atherogenesis in response to a high fat-high cholesterol diet. FEBS Lett 502: 16-20, 2001
14. Joyce CW, Amar MJ, Lambert G, Vaisman BL, Paigen B, Najib-Fruchart J, Hoyt RF Jr, Neufeld ED, Remaley AT, Fredrickson DS, Brewer HB Jr, Santamarina-Fojo S: The ATP-binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc Natl Acad Sci USA 99: 407-412, 2002
15. Ourassa P, Milos PM, Gaynor BJ, Breslow JL, Aiello RT: Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 93: 10022-10027, 1996
16. Srivastava RAK, Srivastava N, Averna M, Lin RC, Korach KS, Lubahn DB, Schonfeld G: Estrogen up-regulates apolipoprotein E (apoE) gene expression by increasing apoE mRNA in the translating pool via the estrogen receptor a-mediated pathway. J Biol Chem 272: 33360-33366, 1997
17. -/- mice. J Clin Invest 107: 333-340, 2001
18. Cavalier LB, Qui Y, Bielicki JK, Afzal V, Cheng J, Rubin EM: Regulation and activity ofthe human ABCA1 gene in transgenic mice. J Biol Chem 276: 18046-18051, 2001
19. Haghpassand M, Bourassa PK, Francone OL, Aiello RJ: Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J Clin Invest 108: 1315-1320, 2001
20. Srivastava RAK, Srivastava N, Averna M: Dietary cholate lowers plasma levels of mouse and human apolipoprotein A1 primarily via a transcriptional mechanism. Eur J Biochem 267: 4272-4280, 2000
21. Bouly M, Masson D, Gross B, Jiang XC, Fievet C, Castro G, Tall AR, Fruchart JC, Staels B, Lagrost L, Luc G: Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate. J Biol Chem 276: 25841-15847, 2001
22. Srivastava RAK, Baumann D, Schonfeld G: In vivo regulation of low density lipoprotein receptor by estrogen differs at the posttranscriptional level in rat and mouse. Eur J Biochem 216: 527-538, 1993
23. Srivastava RAK, Jiao S, Tang J, Pfleger B, Kitchens RT, Schonfeld G: In vivo regulation of low density lipoprotein receptor and apolipoprotein B gene expression by dietary fat and cholesterol in inbred strains of mice. Biochim Biophys Acta 1086: 29-43, 1991
24. Srivastava RAK, Tang J, Krul ES, Pfleger BA, Kitchens RT, Schonfeld G: Dietary fatty acids and cholesterol differ in their effects on the in vivo regulation of apoA1 and apoAII gene expression in inbred strains of mice. Biochim Biophys Acta 1125: 251-261, 1992
25. Srivastava RAK, Srivastava N, Schonfeld G: Expression of low density lipoprotein receptor, apolipoprotein A1, AII, and AIV in various organs utilizing an efficient and rapid method of RNA isolation. Biochem Intern 27: 85-92, 1992
26. Srivastava RAK, Schonfeld G: Using riboprobes for Northern blotting analysis. Bio/Techniques 11: 584-587, 1991
27. Srivastava RAK, Schonfeld G: Quantification of absolute amounts of cellular mRNA by RNA-excess solution hybridization with riboprobes. Meth Mol Biol Prot Gene Anal 31: 273-279, 1994
28. Oram JE, Mendez AJ, Lymp J, Kavanagh TJ, Halbert CL: Reduction in apolipoprotein-mediated removal of cellular lipids by immortalization of human fibroblasts and its reversion by cAMP: Lack of effect with Tangier disease. J Lipid Res 40: 1769-1781, 1999
29. Smith JD, Miyata M, Ginsberg M, Grigaux C, Shmookeler E, Plump AS: Cyclic AMP induces apolipoprotein E binding activity and promoted cholesterol efflux from a macrophage cell line to apolipoprotein acceptors. J Biol Chem 271: 30647-30655, 1996
30. Marsh MM, Walker VR, Curtis LK, Banka CL: Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice. J Lipid Res 40: 893-900, 1999
31. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 5925-5930, 1996
32. Srivastava N, Chowdhury PR, Averna M, Srivastava RAK: Estrogen increases hepatic lipase levels in inbred strains of mice: A possible mechanism for estrogen-dependent lowering of high-density lipoprotein. Mol Cell Biochem 220: 87-93, 2001
33. Saku K, Liu R, Ohta T, Jimi S, Matsuda I, Arakawa K: Plasma HDL levels are regulated by the catabolic rate of large particles of lipoprotein containing apoA-1. Biochem Biophys Res Commun 200: 557-561, 1994
34. Costel P, Luo Y, Wang N, Tall AR: Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 275: 28240-28245, 2000
35. Von Eckardstein A, Langer C, Engel T, Schaukal I, Cignarella A, Reinhardt J, Larkowski S, Li Z, Zhou X, Cullen P, Assman G: ATP-binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte-derived macrophages. FASEB J 15:1555-1561, 2001
36. Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, Brewer HB Jr, Fruchart JC, Clavey V, Staels B: PPAR-α, and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 7: 53-58, 2001